BBNXHIGH SIGNALFINANCIAL10-K

BBNX transformed from a massive $245.4M stockholders' deficit to $287.6M positive equity while dramatically increasing revenue 54% and gross profit 55%, indicating successful IPO capital raise and strong operational momentum.

The 217% equity swing from deeply negative to strongly positive stockholders' equity suggests BBNX completed a significant equity raise (likely their IPO mentioned in removed language) that fundamentally strengthened their balance sheet. However, the 58% deterioration in operating losses despite strong revenue growth indicates the company is investing heavily in growth and has not yet achieved operating leverage.

Comparing 2026-02-24 vs 2025-03-25View on EDGAR →
FINANCIAL ANALYSIS

BBNX experienced a dramatic financial transformation with total assets more than doubling to $328.7M and stockholders' equity swinging from a $245.4M deficit to $287.6M positive, clearly reflecting a major capital raise. Revenue surged 54% to $100.3M with gross profit growing 55% to $55.5M, demonstrating strong top-line momentum, but operating losses deepened 58% to $71.7M as the company scales operations. The overall picture shows a company that has secured substantial funding to fuel aggressive growth in a high-potential market, though profitability remains elusive as investment spending outpaces revenue gains.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+217.2%
-$245.4M$287.6M

Equity base grew 217.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+119.7%
$149.6M$328.7M

Asset base grew 119.7% — expansion through organic growth, acquisitions, or capital deployment.

Current Assets
Balance Sheet
+101.5%
$132.9M$267.9M

Current assets grew 101.5% — improving short-term liquidity or inventory/receivables build.

Inventory
Balance Sheet
+63.1%
$13.3M$21.7M

Inventory surged 63.1% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Operating Income
P&L
-58.4%
-$45.3M-$71.7M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Capital Expenditure
Cash Flow
+56%
$3.4M$5.3M

Capital expenditure jumped 56% — major investment cycle underway; assess returns on deployment.

Gross Profit
P&L
+54.8%
$35.9M$55.5M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Revenue
P&L
+53.9%
$65.1M$100.3M

Strong top-line growth of 53.9% — accelerating demand or successful expansion into new markets.

Current Liabilities
Balance Sheet
+46.2%
$21.1M$30.9M

Current liabilities surged 46.2% — significant near-term obligations; verify ability to meet short-term debt.

Total Liabilities
Balance Sheet
-44.1%
$73.6M$41.1M

Liabilities reduced 44.1% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2026-02-24
PRIOR — 2025-03-25
ADDED
Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.
We have incurred significant operating losses since inception and cannot assure you that we will be able to achieve or sustain profitability.
Our quarterly and annual financial condition, operating results, cash flows and key business metrics may fluctuate in the future, which could cause the market price of our stock to decline substantially.
We may need to raise additional funds in the future, and these funds may not be available on acceptable terms, if at all.
Our results of operations will be harmed if we are unable to accurately forecast customer demand for our products and manage our inventory.
+7 more — sign up free →
REMOVED
The Registrant s Common Stock began trading on the Nasdaq Global Market on January 30, 2025.
Our quarterly and annual financial condition, operating results and cash flows may fluctuate in the future, which could cause the market price of our stock to decline substantially.
Although we consummated our initial public offering and the concurrent private placement, we may need to raise additional funds in the future, and these funds may not be available on acceptable terms, if at all.
Our future success depends on our ability to retain our key personnel and to attract, retain and motivate qualified personnel.
We are developing our iLet in combination with other therapies and devices, which requires additional development time and exposes us to additional risks.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →